Innovation

At the Specialty Food Association’s Summer Fancy Food Show, brands showcased authentically diverse offerings in the refrigerated dip set that lean into health trends and global flavors.

Nissin Foods, the maker of Cup Noodles instant ramen, is targeting GLP-1 weight loss drug users with a new product line debuting this week at the Summer Fancy Food Show in New York. Kanzen Meal, the company’s first foray into the single-serve frozen meal market, was developed using proprietary technology and Japanese culinary techniques to precisely deliver key nutrients while optimizing flavor, according to Nissin Foods.

The Summer Fancy Food Show kicks off this weekend in New York City, and we’ve got our eyes on a handful of standout brands. Here are three on our radar.

Tempeh snack maker Mamame Whole Foods has raised $2 million in a funding round led by Granite Asia, a multi-asset investment platform headquartered in Singapore. The family-owned and operated startup has helped translate a centuries-old superfood into a modern on-the-go snack that entered the U.S. market last fall.

On the CPG Week podcast, Nosh managing editor Monica Watrous and senior reporter Lukas Southard discuss the latest update on low-carb bread maker BetterBrand, a new investment for Momofuku Goods, IPO rumors for Jennifer Garner’s children’s food brand and why one frozen novelties maker is throwing in the towel on its kids’ drinks.

Goodles’ new single-serve microwavable cups, fill a gap for the better-for-you brand in convenience-oriented mac and cheese.

By literally turning the problem on its head, One Trick Pony founder Lucy Dana thinks she’s solved the oil crisis. No, not that one.

This week, the podcast team digs into the disruption caused by a cyberattack on wholesaler UNFI’s information technology systems last week. Next, the hosts discuss Taste Tomorrow Ventures’ first food investment and why sour candy is whetting investor appetites lately. Finally, the podcasters highlight a soccer star’s foray into the consumer packaged goods field and a beverage brand’s latest partnerships.

From pouches to sprays to pastes, on-the-go caffeine consumers searching for portable alternatives to coffee or energy drinks have new formats to choose from.

Lembas, which describes itself as an artificial intelligence-powered peptide discovery company, aims to offer a more accessible alternative to high-priced injectables sold under brand names like Ozempic, Mounjaro and Wegovy with its first solution, GLP-1 Edge.